Nurix Therapeutics, Inc. NRIX Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s common stock shares issued?
- Nurix Therapeutics, Inc. (NRIX) reported common stock shares issued of 103.4M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s common stock shares issued changed year-over-year?
- Nurix Therapeutics, Inc.'s common stock shares issued increased by 35.6% year-over-year, from 76.2M to 103.4M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s common stock shares issued?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s common stock shares issued has grown at a 29.2% compound annual growth rate (CAGR), from 47.2M to 101.8M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.